acetophenone has been researched along with Hepatitis B Virus Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bánhegyi, P; Erös, D; Hafenbradl, D; Hegymegi-Barakonyi, B; Hollósy, F; Kéri, G; Klebl, B; Mészáros, G; Obert, S; Orfi, L; Pató, J; Székelyhidi, Z; Wáczek, F | 1 |
| Kanegae, Y; Kondo, S; Matoba, K; Matsuda, N; Nomoto, A; Saito, I; Yamasaki, M | 1 |
2 other study(ies) available for acetophenone and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives.
Topics: Antiviral Agents; Enzyme Inhibitors; Hepatitis B; Hepatitis B virus; Humans; Inhibitory Concentration 50; Protein Serine-Threonine Kinases; Quinoxalines; Structure-Activity Relationship | 2005 |
Acetophenone 4-nitrophenylhydrazone inhibits Hepatitis B virus replication by modulating capsid assembly.
Topics: Acetophenones; Antiviral Agents; Capsid; Capsid Proteins; Hepatitis B; Hepatitis B virus; Humans; Liver Neoplasms; Virus Assembly; Virus Replication | 2021 |